IIL Stock Overview
A pharmaceutical company, engages in the production and distribution of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Intravenous Infusions Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | GH₵0.05 |
| 52 Week High | GH₵0 |
| 52 Week Low | GH₵0 |
| Beta | 0.46 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | 0% |
| 5 Year Change | 0% |
| Change since IPO | -37.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| IIL | GH Pharmaceuticals | GH Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | 0.8% |
| 1Y | 0% | -9.7% | 57.4% |
Return vs Industry: IIL exceeded the GH Pharmaceuticals industry which returned -9.7% over the past year.
Return vs Market: IIL underperformed the GH Market which returned 57.4% over the past year.
Price Volatility
| IIL volatility | |
|---|---|
| IIL Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 2.2% |
| 10% most volatile stocks in GH Market | 4.3% |
| 10% least volatile stocks in GH Market | 0.3% |
Stable Share Price: IIL's share price has been volatile over the past 3 months compared to the GH market.
Volatility Over Time: Insufficient data to determine IIL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | n/a | Moukhtar Soalihu | www.iil.com.gh |
Intravenous Infusions Plc, a pharmaceutical company, engages in the production and distribution of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region. The company offers pethidine, which includes Chloroquine Phosphate and quinine dihydrochloride injections. Intravenous Infusions Plc was incorporated in 1969 and is based in Koforidua, Ghana.
Intravenous Infusions Plc Fundamentals Summary
| IIL fundamental statistics | |
|---|---|
| Market cap | GH₵13.72m |
| Earnings (TTM) | GH₵949.89k |
| Revenue (TTM) | GH₵30.46m |
14.4x
P/E Ratio0.5x
P/S RatioIs IIL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IIL income statement (TTM) | |
|---|---|
| Revenue | GH₵30.46m |
| Cost of Revenue | GH₵14.31m |
| Gross Profit | GH₵16.15m |
| Other Expenses | GH₵15.20m |
| Earnings | GH₵949.89k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0035 |
| Gross Margin | 53.02% |
| Net Profit Margin | 3.12% |
| Debt/Equity Ratio | 62.1% |
How did IIL perform over the long term?
See historical performance and comparisonDividends
5.6%
Current Dividend Yield30%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 00:23 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Intravenous Infusions Plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|